|
% Vaccination coverage (with 95% CI)
|
Rate ratios for non-uptake among children with intellectual disability (reference group = other children)
|
---|
Children with intellectual disabilities
|
Other children
|
Unadjusted
|
Model 1 (SEP)
|
Model 2 (SEP + other factors)
|
---|
Age 9 months
|
(n = 551)
|
(n = 17,986)
| | | |
Fully or partially vaccinated
|
97.6% (95.7–98.6)
|
98.7% (98.5–99.0)
|
1.93 (1.09–3.43)*
|
1.33 (0.69–2.57)
|
1.33 (0.71–2.53)
|
Fully vaccinated
|
89.5% (86.2–92.1)
|
95.2% (94.8–95.7)
|
2.03 (1.14–3.60)*
|
1.38 (0.71–2.637)
|
1.38 (0.73–2.63)
|
Partially vaccinated
|
8.0% (5.8–11.0)
|
3.5% (3.2–3.9)
|
0.88 (0.53–1.47)
|
0.90 (0.50–1.63)
|
0.96 (0.54–1.70)
|
No vaccinations
|
2.4% (1.4–4.3)
|
1.3% (1.1–1.6)
| | | |
Age 3 years
|
(n = 521)
|
(n = 14,261)
| | | |
Polio complete
|
97.3% (95.1–98.6)
|
98.8% (98.6–99.0)
|
2.27 (1.20–4.29)*
|
2.22 (1.16–4.23)*
|
2.18 (1.13–4.19)*
|
Diptheria complete
|
98.2% (96.3–99.1)
|
98.8% (98.6–99.1)
|
1.59 (0.78–3.23)
|
1.48 (0.70–3.13)
|
1.47 (0.70–3.15)
|
Tetanus complete
|
97.7% (95.8–98.8)
|
98.9% (98.6–99.1)
|
2.02 (1.07–3.82)*
|
1.89 (0.97–3.66)
|
1.90 (0.97–3.71)
|
Pertussis complete
|
96.4% (93.8–98.0)
|
98.4% (98.1–98.7)
|
2.23 (1.27–3.92)**
|
2.07 (1.16–3.70)*
|
2.12 (1.19–3.79)*
|
Hib complete
|
96.5% (93.9–98.0)
|
98.2% (97.8–98.5)
|
1.95 (1.10–3.45)*
|
1.78 (0.98–3.23)
|
1.78 (0.98–3.23)
|
Meningitis complete
|
96.7% (94.2–98.1)
|
98.1% (97.7–98.4)
|
1.73 (0.98–3.07)
|
1.59 (0.87–2.92)
|
1.62 (0.87–3.01)
|
MMR
|
91.6% (88.1–94.2)
|
93.9% (93.2–94.6)
|
1.38 (0.96–1.09)
|
1.24 (0.85–1.80)
|
1.18 (0.81–1.72)
|
Fully or partially vaccinated
|
98.1% (96.2–99.0)
|
99.1% (98.8–99.3)
|
2.06 (1.01–4.22)*
|
1.77 (0.82–3.79)
|
1.78 (0.83–3.81)
|
Fully vaccinated
|
84.9% (80.8–88.3)
|
90.1% (89.2–90.9)
|
2.16 (1.06–4.43)*
|
1.82 (0.85–3.92)
|
1.83 (0.86–3.91)
|
Partially vaccinated
|
13.2% (10.1–17.1)
|
9.0% (8.2–9.7)
|
1.35 (0.70–2.63)
|
1.35 (0.66–2.77)
|
1.35 (0.66–2.75)
|
No vaccinations
|
1.9% (1.0–3.8)
|
0.9% (0.7–1.2)
| | | |
Age 5 years
|
(n = 524)
|
(n = 14,365)
| | | |
Booster DTP
|
94.5% (91.9–96.3)
|
96.0% (95.5–96.4)
|
1.38 (0.92–2.06)
|
1.19 (0.79–1.79)
|
1.17 (0.77–1.77)
|
All 3 doses combined DTP
|
98.7% (97.0–99.5)
|
99.2% (98.9–99.4)
|
1.56 (0.64–3.81)
|
1.43 (0.54–3.77)
|
1.36 (0.51–3.63)
|
Booster polio
|
94.9% (92.4–96.7)
|
95.2% (94.6–95.7)
|
1.06 (0.69–1.61)
|
0.99 (0.64–1.94)
|
0.98 (0.63–1.54)
|
All three doses Polio
|
98.7% (97.1–99.5)
|
99.2% (99.0–99.4)
|
1.61 (0.68–3.79)
|
1.57 (0.62–4.01)
|
1.51 (0.60–3.84)
|
All 3 doses Meningitis C
|
97.8% (95.5–98.9)
|
98.4% (98.1–98.7)
|
1.40 (0.70–2.82)
|
1.33 (0.63–2.79)
|
1.32 (0.63–2.74)
|
MMR
|
96.9% (95.0–98.1)
|
96.8% (96.2–97.2)
|
0.96 (0.58–1.58)
|
1.07 (0.64–1.79)
|
1.01 (0.60–1.70)
|
Fully or partially vaccinated
|
99.1% (97.4–99.7)
|
99.5% (99.3–99.6)
|
1.88 (0.66–5.39)
|
2.01 (0.61–6.59)
|
1.93 (0.59–6.35)
|
Fully vaccinated
|
87.4% (83.9–90.2)
|
89.3% (88.4–90.1)
|
1.91 (0.67–5.49)
|
1.97 (0.60–6.44)
|
1.88 (0.58–6.13)
|
Partially vaccinated
|
11.7% (9.1–14.9)
|
10.2% (9.5–11.1)
|
1.60 (0.59–4.36)
|
2.18 (0.69–6.88)
|
2.20 (0.72–6.77)
|
No vaccinations
|
1.0% (0.3–2.7)
|
0.5% (0.4–0.7)
| | | |
Age 14 years
|
(n = 149)
|
(n = 4938)
| | | |
HPV (girls only)
|
87.4% (77.9–93.2)
|
93.1% (92.1–94.0)
|
1.83 (0.99–3.37)
|
1.59 (0.83–3.03)
|
1.52 (0.78–2.98)
|
- Note: * p < 0.05, ** p < 0.01, *** p < 0.001
- N = weighted sample size